Related Experiment Video
Updated: Nov 7, 2025

Daily Phototherapy with Red Light to Regulate Candida albicans Biofilm Growth
Published on: April 23, 2019
Evaluating the efficacy of anti-fungal blue light therapies via analyzing tissue section images
Yun Zhao1,2, Yunchu Zhang1,2, Jianfei Dong3
1University of Science and Technology of China, Hefei, China.
Abstract:
Anti-fungal blue light (ABL) therapies have been studied and applied in treating various diseases caused by fungal infection. The existing work has been mainly devoted to study the effect of various light dosages on the fungal viability and on the induced cytotoxic reactive oxygen species (ROS) in the pathogens. While in vivo experimental studies have also been reported, there is still no work targeted on quantifying the effect of light on prohibiting the pathogens from invading into the deeper sites in the skin of their host. This can be attributed to the lack of methods to analyze the tissue section images, which are the main means of examining infected tissues. This work has been devoted to solve such problems, so as to improve dosimetric analyses of ABL therapies on treating fungal infections. Specifically, the invasion depth of the fungi and their ratios to the tissue in four bins at different depths inside the skin were extracted from the tissue section images. The significance of the treatment with different dosages on inhibiting the fungi was also tested by each of these depth-related metrics. The ABL experiments using 415-nm-wavelength LED light were performed on BALB/c mice, whose skin was infected by Candida albicans (C. albicans). The proposed methods were applied to the tissue sections of the experimental animals. The results clearly verified that the fluence up to 180J/cm2 can significantly prohibit the fungal infection into the skin in terms of almost all the newly proposed metrics.
Insights
Anti-fungal blue light (ABL) therapy effectively inhibits fungal skin infections. New methods quantify ABL
Area of Science:
- Photomedicine
- Dermatology
- Medical Mycology
Background:
- Anti-fungal blue light (ABL) therapies are used for fungal infections.
- Existing research focuses on fungal viability and reactive oxygen species (ROS) production.
- Quantifying ABL's effect on preventing deeper fungal invasion in host skin is lacking.
Purpose of the Study:
- To develop methods for analyzing tissue sections to quantify fungal invasion depth.
- To improve dosimetric analyses for ABL therapies against fungal infections.
- To evaluate the efficacy of ABL in inhibiting fungal invasion into deeper skin layers.
Main Methods:
- ABL experiments using 415-nm LED light on BALB/c mice infected with Candida albicans.
- Development of methods to extract fungal invasion depth and tissue ratios from skin section images.
- Statistical analysis of depth-related metrics to assess treatment significance.
Main Results:
- ABL treatment significantly inhibited fungal infection into the skin.
- Fluence up to 180 J/cm² demonstrated effectiveness across multiple depth-related metrics.
- The proposed methods successfully quantified the impact of ABL on fungal invasion.
Conclusions:
- ABL therapy, particularly at fluences up to 180 J/cm², is effective in preventing deeper fungal skin invasion.
- Novel image analysis methods enable quantitative assessment of ABL efficacy in vivo.
- This work advances the understanding and application of ABL for treating fungal skin infections.

